Although some studies claim an increase incidence of venous thromboembolism with erythropoietin use [13, 14], systematic review and network meta‐analysis done by Zheng et al. revealed no statistical differences or closed links between node networks on erythropoietin use and the incidence of deep vein thrombosis and PE [15]. The gene discussed is EPO; the disease is deep vein thrombosis.